Chemokines regulate proliferation and migration of various types of normal stem and progenitor cells, including precursor cells of neuroectodermal origin. Based on this it is conceivable that the established role of chemokines in cancer cell proliferation and organ specific-metastasis might also be associated with stem cell-like cells present in the tumor. Such cancer stem cells (CSCs) represent a small subpopulation of tumor cells that are thought to initiate and sustain tumor formation. More recently, characteristics of stem cells have also been observed in metastatic cancer cells, and it has been suggested that CSCs might play a crucial role in the metastatic process as such. Intriguingly, first evidence has been provided that the metastatic spread of specific CSCs is driven by chemokine signaling. Thus it is possible that chemokinemediated CSC regulation might be a general feature of metastasis formation.
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Introduction
A wealth of data suggests that chemokine signaling can contribute to tumorigenesis and metastases [1] . In particular, a strong correlation between chemokine receptor expression and organ-specific metastasis formation has been described for many different types of solid cancers [2] [3] [4] [5] [6] [7] [8] [9] [10] . It is assumed that chemokine receptorexpressing cancer cells home to organs that express high levels of the appropriate ligand. Thereby, the chemokine axis involved appears to be specific both for the cancer cell type and the target organ. For instance, in breast cancer, expression of both CXCR4 and CCR7 predicts lung and lymph node metastases [11] . In melanoma, however, CXCR4 is highly associated with pulmonary [12, 13] and liver [14] metastasis formation, whereas CCR7 and CXCR3 were associated with lymph node metastases [12, [15] [16] [17] [18] . In addition, CCR10 is predominantly expressed by keratinocytes and associated with melanoma-derived skin metastasis [12] , while CCR9 has been linked to small intestinal melanoma metastases [19, 20] . In neuroblastoma, CXCR4 expression is strongly correlated with bone and bone marrow metastases [21, 22] . Studies of Zhang and colleagues recently demonstrated an influence of tissue stromal cells on CXCR4 expression levels in neuroblastoma cells [22] . Moreover, neuroblastoma cells showed CXCR4 up-regulation when cultivated with liver and bone marrow preconditioned media suggesting that the specific microenvironment plays a pivotal role to promote metastases outgrowth [22] .
Recently, however, it has been shown that CXCR4 has no significant influence on the number or pattern of neuroblastoma metastasis. Rather, a strong growth-promoting effect was observed, potentially representing the main role of CXCR4 in neuroblastoma progression [23] . Moreover, intracranial glioblastoma and medulloblastoma xenografts treated with a CXCR4 antagonist (AMD3100) showed reduced cell growth and increased tumor cell apoptosis [24] . Thus, although chemokine signaling in cancer has predominantly been associated with organ-specific metastasis, other cellular processes also appear to be controlled by these molecules.
Likely, the mode of chemokine action depends on the cancer cell type affected, as cell intrinsic properties determine the cells response to a specific chemokine ligand/receptor pair. Similarly, during development, cell fates are regulated by the combinatorial activities of intrinsic cues and extracellular factors [25] . Therefore, given the parallels between tumor formation and embryonic development and in view 4 of the recent discovery of tumor-initiating cells sharing certain properties of normal stem cells [26] , it might be valuable to consider chemokine function in cancer with the eyes of a developmental biologist. In this review, we will first give a brief overview on neuroectodermal development and discuss how chemokines affect precursor cells originating from the neuroectoderm and other tissues. We will then extend this discussion to possible associations between chemokine signaling and metastasizing cancer stem cells. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 5 epithelium, and thus maintain an epithelial character. Subsequently, NC cells undergo an epithelial-mesenchymal transition (EMT) [34] , delaminate from the epithelium, and extensively migrate throughout the embryo before differentiation. EMT is a key biological process occurring during embryonic development, tissue remodeling, and wound repair, allowing epithelial cells to escape from the rigid structural constraints provided by the tissue architecture and to adopt a phenotype more permissive for cell migration [34] . Essentially, during this event, epithelial cells actively downregulate cell-cell adhesion, lose their polarity, and acquire a mesenchymal phenotype with reduced intercellular interactions and increased migratory capacity. EMT of NC cells represents a paradigmatic example during embryogenesis. During EMT, NC cells lose N-cadherin-mediated cell-cell adhesion while becoming excluded from the neural epithelium [35] . When NC cells are released from the neural epithelium, they concomitantly upregulate genes required for a mesenchymal phenotype and migratory ability. These include transcription factors such as Slug or Snail, AP-2, Foxd3, PAX3, Twist, Sox9, and others [36] . Furthermore, NC cell induction and delamination are promoted by specific signaling pathways, including BMP4 and Wnt signal activation [37] [38] [39] .
Precursor cells in neuroectodermal development
Immediately after delamination, NC cells start to migrate either ventrally close to the neural tube or dorso-laterally in proximity to the somatic ectoderm [40, 41] . At least a subpopulation of migratory NC cells display stem cell properties, being multipotent and able to self-renew [42] . By largely unknown mechanisms, which may depend on their progenitor state, NC cells stop migrating and subsequently differentiate into specialized cell types. However, there is multiple evidence that multipotent cells with stem cell features (so-called NC-derived stem cells, NCSCs) persist in NC target structures, including in the adult organism. Notably, cells very similar to embryonic NCSCs in terms of marker expression and differentiation program have been isolated from the adult heart [43] , gut [44] , bone marrow [45] , and skin [46] [47] [48] Chemokines regulating neural precursor cell migration and proliferation 6 The fate of CNS and NC stem cells is largely dependent on a finely tuned, stage-and area-specific interplay between the extracellular environment and intracellular regulatory cues. Various growth factors including sonic hedgehog (Shh), Wnt, and transforming growth factor (TGF)ß are known to control the balance between stem cell proliferation and differentiation both in the CNS and during NC development With respect to chemokines, comprehensive studies of neural stem cell-specific functions are scarce. However, several reports point to a role of chemokine signaling at early cellular stages, indicating an involvement in precursor cell proliferation and migration. Examination of embryonic neural progenitor cells in culture has confirmed that these cells express CXCR4 and that its unique ligand CXCL12 can act as a chemoattractant [54] [55] [56] [57] . Deletion of the genes for the CXCR4 chemokine receptor or for CXCL12 is lethal at a relatively late stage of embryogenesis [58, 59] . CXCR4 or CXCL12-deficient embryos exhibit a large number of phenotypes, including defects in the cardiovascular, gastrointestinal, and nervous systems, in addition to the immune system [58] [59] [60] [61] . In the nervous system, the development of the cerebellum, hippocampal dentate gyrus, cortex, and dorsal root ganglia (DRG) are all affected [59, [62] [63] [64] [65] and deficits in the migration and proliferation of oligodendrocyte progenitors have also been observed [66, 67] . The expression patterns of CXCL12 and CXCR4 during embryogenesis [68, 69] indicates that all of these developmental phenotypes could possibly be explained on the basis of deficits in CXCL12-mediated attraction of embryonic neural precursor cells. This is best illustrated by the cerebellar phenotype of CXCL12 and CXCR4 knockout mice [58, 59] . During development of the cerebellum, cerebellar granule cell progenitors are restricted to the external granule cell layer, where they proliferate. Once the pool of progenitors has expanded, post-mitotic cells migrate to the internal granule cell layer, the normal location for mature granule cells. In CXCR4 and CXCL12-deficient mice granule cell progenitors proceeded with their migration at an improperly early time, causing the progenitors to locate ectopically within the Purkinje cell layer. In this system, CXCL12 signal 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   7 maintains progenitors within the external granule cell layer [70, 71] . Upon inactivation of CXCR4 the progenitors escape the confines of the external granule cell layer, leading to their inappropriately early migration.
Similarly, in the hippocampal dentate gyrus, deletion of CXCR4 results in ectopically placed granule cells along the normal way of granule cell progenitor migration [62, 63] . Granule cell progenitors move from the wall of the lateral ventricle immediately after birth driven by meningeal cells secreting CXCL12. Abolishing CXCR4 expression on the granule cell progenitors, therefore, delays migration, explaining the observed phenotype. Other neuronal phenotypes apparent in CXCR4 knockout mice include defects in the placement of a specific subpopulation of forebrain neurons, Cajal-Retzius cells, and cortical GABAergic interneurons [64, [72] [73] [74] [75] . In all of these situations, the progenitors for these neurons employ CXCL12-mediated chemoattraction to accomplish their final positioning, and lack of CXCR4 signaling results, therefore, in interrupted progenitor migration.
During NC cell development, the chemokine CCL5 (RANTES) has been described to drive migration of primary neurons in DRGs [76] . Similarly, CXCR4 expressed on migratory cells regulates migration of NC-derived sensory neuronal progenitor cells into DRGs (Fig. 1B) [65] . CXCR4 or CXCL12 are also involved in cardiac development. During development of the heart, a subpopulation of cardiac NC cells migrate to colonize the outflow tract endocardial cushions prior to septation, the process through which a single outflow vessel, the truncus arteriosus, develops into the ascending aorta and the pulmonary trunk [77] . However, in both CXCR4 and CXCL12-deficient mice the region of the ventricular septum is abnormal [59, 78] .
Since CXCL12 is expressed in the developing heart tissue [68] and CXCR4 is expressed in migrating cells of the NC [65] , it is conceivable that disrupted 'homing' of mutant cells to their target organ brings about this phenotype (Fig. 1B) , consistent with the defects observed in CXCR4-mutant DRG. Likewise, mutation of CXCL12, a chemoattractant for NC-derived melanophores in zebrafish, results in ectopic melanophore migration and disturbed pigment patterning in this system (Fig. 1B) [79].
Apart from migration, chemokine signaling can also influence the number of neural precursor cells. For instance, CXCL12 is a mitogenic cue for postnatal mouse neural progenitor cells [80] and various human neural progenitor cell lines [81] . However, in 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   8 human hippocampal neural precursors, CXCL12 has also been reported to promote survival and maintenance in a quiescent state, rather than inducing cell cycle progression [54] . The use of cell lines from different stages or brain areas might possibly explain the discrepancy between these studies, which emphasizes again that one and the same chemokine can elicit different effects in distinct cell types of neuroectodermal origin.
The role of chemokines in regulating precursor cell development is not exclusive to the nervous system. Functional CXCR4 is found on the surface of several tissue committed stem/progenitor cells, such as haematopoietic stem cells [82] , primordial germ cells [83] , skeletal muscle satellite progenitor cells [84] , liver progenitor cells [85] , and retinal pigment epithelium progenitors [86] . Functional CXCR4 is also expressed on murine embryonic stem cells. In mice deficient for CXCL12 or CXCR4, primitive hematopoietic stem cells fail to localize to the bone marrow, the site of hematopoiesis at postnatal stages [58, 59] . A further interesting phenotype identified in CXCL12/CXCR4 knockout mice is a deficiency in blood vessel development, as initially observed in the gastrointestinal system [60] . Consistent with these observations, CXCR4 is expressed by hemangioblasts [87] and endothelial cells derived from embryonic stem cells in culture [88] . In the latter situation the endothelial cells expressed CXCR4 and migrated towards a CXCL12 gradient.
Therefore, there is strong indication that CXCR4 signaling in endothelial progenitors has a substantial impact on vascularization in the embryo. Finally, analysis of primordial germ cell migration in zebrafish, in which genes for CXCL12 or CXCR4 have been deleted, shows aberrant colonization of the gonads by these cells [89] . The combined data suggest that chemokine signaling might play a general role during tissue regeneration and repair, e.g. by chemoattraction of CXCR4-positive stem or progenitor cells to a specific tissue.
Cancer stem cells in neuroectodermal tumors
The fundamental functions of chemokines in spread and proliferation of normal stem and progenitors cells raises the hypothesis that chemokines might elicit similar effects in specific cancer cell subpopulations, the so-called cancer stem cells (CSCs).
Growing evidence over the past few years has revealed that distinct populations of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   9 cancer cells with features of stem cells play a crucial role in the development and progression of tumors [90, 91] . As currently defined, a CSC represents a cell within a tumor that is able to self-renew in vitro and in vivo, is exclusively tumorigenic even at low cell numbers, and is capable of reproducing the cellular heterogeneity found in the parental tumor [90] . Therefore, it should be achievable to identify the cells responsible for de novo tumor formation based on their distinct phenotypic and functional characteristics [92] . Indeed, tumor-initiating CSCs with specific properties and marker expression have been identified in several malignancies including blood, skin, breast, ovarian, prostate cancers, and neuroectodermal tumors [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] .
As their name implies, neuroectodermal tumors arise from adult tissue originating from the embryonic neuroectoderm. As derivatives of CNS cells, neuroectodermal tumors include medulloblastoma, oligodendroglioma, oligodendrocytoma, and astrocytoma. Another class of neuroectodermal tumors have a NC cell origin and comprise, among others, neurofibroma, schwannoma, neuroblastoma, malignant nerve sheath tumor, and melanoma [106, 107] . Clinically, the classification of neurological tumors is based on the predominant cell type(s), which is generally determined by morphological and immunohistochemical criteria (Fig. 2) . Although not all neuroectodermal neoplasms have yet been shown to contain CSCs, the existence of brain tumor stem cells has, for instance, been described for both adult and pediatric gliomas and for malignant medulloblastomas [108] [109] [110] . Interestingly, CSCs from these brain tumors express many genes characteristic of CNS stem cells, including Sox2, musashi-1, bmi-1, and CD133 (Prominin-1) [109] [110] [111] .
An involvement of CSCs in tumor initiation and progression, chemoresistance and therapeutic failure has also been reported for human melanoma, the most fatal skin cancer [112] [113] [114] [115] [116] [117] . Similar to normal tissues, melanomas consist of phenotypically heterogeneous cell populations in accordance with the idea that these tumors arise from multipotent cells [112, 113, [118] [119] [120] . Indeed, various cell culture and in vivo transplantation experiments indicated the existence melanoma cell subpopulations with stem cell-like differentiation capacity and increased tumorigenic potential [112, 116, 120] . Thus, malignant melanoma stem cells may contribute to natural progression and therapeutic failure in this disease.
Despite the growing evidence for CSCs underlying neuroectodermal tumor formation, their cellular origin remains unclear. One possibility is that they arise by 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Nonetheless, CSCs could also arise by de-differentiation upon transformation of more mature cells. For instance, normal pigmented melanocytes can give rise to less differentiated cells, although these have a somewhat more limited potential than NCSCs [121] . Recently, neurofibroma -a tumor arising around peripheral nerves-has been suggested to develop from differentiated adult cells rather than stem cells [122, 123] . Neurofibroma is caused by a defective version of the protein neurofibromin (NF1) that normally acts as a brake preventing cells in the nervous system from overproliferation [106] . Neurofibromas are composed of a mixture of cells, consistent with an involvement of a multipotent cell in tumor formation.
However, NF1-mutant NCSCs differentiate into the expected cell types and are unable to initiate tumor formation upon transplantation into adult nerves [122] .
Moreover, inactivation of the NF1 gene induced a marked increase in proliferation of non-myelinating Schwann cells rather than of undifferentiated stem cells [123] . Still, these data do not exclude that other tumors, as for instance melanoma, might originate from transformation of normal stem cells, as it is well conceivable that different tumor types with different aggressiveness might arise from distinct cell types.
Chemokines in cancer stem cells and metastasis
CSCs may not only be associated with tumor initiation and growth but also with metastasis formation: if CSCs represent the only cell population with tumor-initiating potential, one would hypothesize that solely CSCs are capable of generating tumor metastases [124] . It has even been proposed that cancer cells adopt stem cell features only upon undergoing EMT. Indeed, induction of EMT in immortalized human mammary epithelial cells resulted in the expression of stem-cell markers, the gain of mesenchymal behavior, and phenotypes associated with CSCs [125] . These findings illustrated a direct link between EMT and gain of properties characteristic for migratory stem cells (Fig. 3) . It remains to be shown, however, whether this is a general phenomenon of metastasis formation. For instance, in tumors derived from NC structures, CSCs in primary tumors might share properties with normal NCSCs that are already endowed with an intrinsic capacity to migrate. This hypothesis could 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   11 offer an explanation for why neuroectodermal tumors of NC cell origin, such as melanoma, are highly metastatic and aggressive.
As mentioned above, EMT is characterized by the expression of various factors responsible for mediating this process at the molecular level. It is interesting but not surprising that many of these molecules have also been associated with tumor progression [126] . Little is known regarding the type of EMT induced by chemokine system(s) despite abundant evidence of the diverse malignant behaviors of such systems in cancer cells. In a model of EMT in colon carcinoma an upregulation of CXCL8 and its cognate chemokine receptor CXCR1 has been observed. In this study, both CXCL8 and CXCR1 were involved in the chemokinetic and chemotactic migration of colon carcinoma cells as assessed by antibody inhibition, establishing that the regulated expression of a specific chemokine and its receptor are linked to EMT [127] . Similarly, Onoue and colleagues demonstrated that CXCL12/CXCR4 signaling induces EMT in oral squamous cell carcinoma (SCC) [128] . In addition, it has been suggested that EMT induced by the CXCL12/CXCR4 system might also be involved in lymph node metastasis of oral SCC [4] . CSCs and express higher levels of CXCR4 [129] . All together, these results suggest that CSCs may indeed be involved in metastasis formation and, furthermore, be partially controlled by chemokine signaling (Fig. 4) . These preliminary data together with the reported role of various chemokines in metastasis strongly support the idea that migrating CSCs could play a key function in chemokine-mediated metastasis of cancer. Interestingly, AMD3100, a specific pharmacological inhibitor of the CXCR4
receptor, strongly inhibits metastatic activity of unselected murine pancreatic cancer cells [130] as well as purified CSCs [96] , and the fact that AMD3100 is already evaluated in ongoing clinical trials make it a candidate for further experimental studies on CSC-mediated metastasis [131, 132] .
Conclusion
In recent years, the field of cancer research has gained many novel insights into the cellular and molecular processes underlying tumor growth, dissemination of tumor cells, and metastasis. Tumor-initiating cancer cells with stem cell properties have been identified in a wide range of cancers including several neuroectodermal tumors, and there is good evidence that CSCs might be implicated in the generation of metastases. This model would also explain the low efficiency of the metastatic process, since only a small fraction of cells would be responsible for initiating and sustaining a new metastatic lesion. However, there remain at least as many questions to be addressed as have been resolved to date. In pancreatic cancer -the only tumor for which a direct association between CSCs, chemokine signaling, and metastasis has been provided so far-the CSC in question was reported to express the stem cell marker CD133 [96] . However, in colon cancer, cells negative for CD133 recently turned out to have a metastatic potential comparable to the one of CD133-positive cells, and metastatic CD133-negative cells form even more aggressive tumors [133] .
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